Chris Ho-ming Wong
Papers
2
Total Citations
14
H-Index
2
About
Dr. Chris Ho-ming Wong is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for patients with bladder cancer, particularly through robot-assisted radical cystectomy (RARC). His major contributions center on comparing long-term outcomes of urinary diversion techniques—specifically orthotopic neobladder versus ileal conduit—following RARC. As a key member of the Asian RARC Consortium, Dr. Wong spearheaded a landmark multicenter study (2024, 12 citations) that provides critical evidence on the optimal method of urinary diversion, addressing a long-standing gap in the literature. This work has significant implications for improving quality of life and survival in muscle-invasive bladder cancer patients. His research is widely cited and has helped shape clinical guidelines in Asia and beyond. Dr. Wong’s collaborative, data-driven approach underscores his commitment to advancing minimally invasive surgical techniques and patient-centered outcomes. His findings continue to influence urologic practice, making him a respected voice in the field of robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2